FMP

FMP

Enter

APRE - Aprea Therapeutics, ...

Financial Summary of Aprea Therapeutics, Inc.(APRE), Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and comm

photo-url-https://financialmodelingprep.com/image-stock/APRE.png

Aprea Therapeutics, Inc.

APRE

NASDAQ

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

4.07 USD

0.02 (0.491%)

About

ceo

Dr. Oren Gilad Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://atrinpharma.com

exchange

NASDAQ

Description

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

CIK

0001781983

ISIN

US03836J2015

CUSIP

03836J102

Address

535 Boylston St.

Phone

617-463-9385

Country

US

Employee

7

IPO Date

Oct 3, 2019

Summary

CIK

0001781983

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

03836J102

ISIN

US03836J2015

Country

US

Price

4.07

Beta

1.98

Volume Avg.

10.01k

Market Cap

22.1M

Shares

-

52-Week

2.78-8.847

DCF

6.72

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.24

P/B

-

Website

https://atrinpharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest APRE News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep